Jackie Hunter

{{short description|British scientist}}

{{for|the Canadian actor, singer and musician|Jackie Hunter (entertainer)}}

{{Third-party|date=February 2021}}

{{EngvarB|date=November 2017}}

{{Use dmy dates|date=November 2017}}

{{Infobox scientist

| name = Jackie Hunter

| native_name_lang =

| image =

| image_size =

| alt =

| caption =

| birth_name = Ann Jacqueline Hunter{{Scopus|id=57207486697}}

| birth_date = {{Birth year and age|1956}}{{cite web |url=http://www.rhul.ac.uk/alumni/ouralumni/notablealumni/biologicalsciences/drjackiehuntercbe(1956-).aspx |title=Royal Holloway, University of London Dr Jackie Hunter CBE (1956–) |archivedate=24 September 2016 |archiveurl=https://web.archive.org/web/20160924181220/http://www.rhul.ac.uk/alumni/ouralumni/notablealumni/biologicalsciences/drjackiehuntercbe(1956-).aspx |url-status=dead |access-date=11 November 2013 }}

| birth_place =

| death_date =

| death_place =

| resting_place =

| resting_place_coordinates =

| other_names =

| residence =

| citizenship =

| nationality =

| fields =

| workplaces = {{Plainlist|

| alma_mater = Bedford College, London

| thesis_title = Chemical communication, aggression and sexual behaviour in the owl monkey (Aotus trivirgatus griseimembra)

| thesis_url = http://ethos.bl.uk/OrderDetails.do?uin=uk.bl.ethos.258402

| thesis_year = 1981

| doctoral_advisor =

| academic_advisors =

| doctoral_students =

| notable_students =

| known_for = {{Plainlist|

AI and Drug discovery

| author_abbrev_bot =

| author_abbrev_zoo =

| influences =

| influenced =

| awards = {{Plainlist|

FRSB (2016)

| signature =

| signature_alt =

| website = {{URL|benevolent.ai/blog/}}

| footnotes =

| spouse =

| children =

}}Ann Jacqueline Hunter CBE FMedSci FBPharmacolS FRSB is a British scientist who is a board director of BenevolentAI.{{Cite web|url=https://www.babraham.com/news-events/2019/benevolent-ai-s-dr-jackie-hunter-discusses-defining-innovation/|title=Benevolent AI's Dr Jackie Hunter discusses defining innovation - Babraham Research Campus|website=www.babraham.com|access-date=2020-01-08}} Hunter is also a visiting professor at St George's Hospital Medical School and Imperial College. She is Chair of the Trustees of the Sainsbury Laboratories at Norwich, chair of the board of the Stevenage Bioscience Catalyst and chair of the board of Brainomix. She was previously CEO of the Biotechnology and Biological Sciences Research Council.{{cite web|url=http://www.bbsrc.ac.uk/organisation/structures/executive/chief-executive.aspx |title=Chief Executive's biography: Professor Jackie Hunter |archivedate=4 December 2013 |archiveurl=https://web.archive.org/web/20131204214455/http://www.bbsrc.ac.uk/organisation/structures/executive/chief-executive.aspx |url-status=dead }}[http://www.timeshighereducation.co.uk/news/jackie-hunter-to-be-next-bbsrc-chief/2004330.article Jackie Hunter to be next BBSRC chief, Times Higher Education, 4 June 2013]

Education

Jackie Hunter was educated at Selwyn School, Matson, Gloucestershire and at the King's School, Gloucester.{{cite web|url=http://www.linkedin.com/in/drjackiehunter |title=Jackie Hunter PhD CBE FBPharmacolS LinkedIn profile |archivedate=8 November 2013 |archiveurl=https://archive.today/20131108112840/http://www.linkedin.com/in/drjackiehunter |url-status=dead }} She achieved a BSc in Physiology and Psychology at Bedford College, University of London in 1977 and whilst there represented the college on the TV programme University Challenge in 1976. She was awarded her PhD{{cite thesis |degree=PhD |first=A. Jackie|last=Hunter |title=Chemical communication, aggression and sexual behaviour in the owl monkey (Aotus trivirgatus griseimembra) |publisher=Bedford College, London |year=1981 |url=http://ethos.bl.uk/OrderDetails.do?uin=uk.bl.ethos.258402|authorlink=Jackie Hunter}} for work carried out at London Zoo entitled 'Olfaction, aggression and sexual behaviour of owl monkeys (genus Aotus) in 1981.

Career

Hunter undertook a Wellcome Trust Postdoctoral research fellowship at St George's Hospital Medical School before joining the pharmaceutical industry. She worked at Glaxo Laboratories first in Greenford and then Ware on novel therapeutics for Alzheimer's disease. In 1986 she moved to Astra and then subsequently in 1989 to SmithKline and French just prior to the merger that created SmithKlineBeecham (SB). At SB she held a number of management positions and was responsible for delivering a number of candidate molecules to development as well as large-scale external collaborations such as the ENU mutagenesis project with the MRC at Harwell. After the merger between SB and GlaxoWellcome to create GSK, she became head of the Neurology and GI Centre of Excellence for Drug Discovery and Site Head at the GSK site in Harlow, Essex.

In 2008, Hunter developed GSK's external innovation strategy and was responsible for developing the concept of the Stevenage Bioscience Catalyst and obtaining funding from government and other bodies.{{citation needed|date=February 2021}} In 2010, she left GSK to establish OI Pharma Partners.{{cite web|url=http://www.oipharmapartners.com |title=OI Pharma Partners – Open Innovation in Healthcare |archivedate=31 October 2013 |archiveurl=https://web.archive.org/web/20131031174408/http://www.oipharmapartners.com/ |url-status=dead }}{{Cite journal | last1 = Hunter | first1 = J.| authorlink = Jackie Hunter| title = Challenges for pharmaceutical industry: New partnerships for sustainable human health | doi = 10.1098/rsta.2010.0377 | journal = Philosophical Transactions of the Royal Society A: Mathematical, Physical and Engineering Sciences | volume = 369 | issue = 1942 | pages = 1817–1825 | year = 2011 | pmid = 21464073|bibcode = 2011RSPTA.369.1817H | doi-access = }}{{Cite journal

| doi = 10.1073/pnas.96.19.10911

| last1 = Hagan | first1 = J. J.

| last2 = Leslie | first2 = R. A.

| last3 = Patel | first3 = S.

| last4 = Evans | first4 = M. L.

| last5 = Wattam | first5 = T. A.

| last6 = Holmes | first6 = S.

| last7 = Benham | first7 = C. D.

| last8 = Taylor | first8 = S. G.

| last9 = Routledge | first9 = C.

| last10 = Hemmati | first10 = P.

| last11 = Munton | first11 = R. P.

| last12 = Ashmeade | first12 = T. E.

| last13 = Shah | first13 = A. S.

| last14 = Hatcher | first14 = J. P.

| last15 = Hatcher | first15 = P. D.

| last16 = Jones | first16 = D. N.

| last17 = Smith | first17 = M. I.

| last18 = Piper | first18 = D. C.

| last19 = Hunter | first19 = A. J.

| last20 = Porter | first20 = R. A.

| last21 = Upton | first21 = N.

| title = Orexin a activates locus coeruleus cell firing and increases arousal in the rat

| journal = Proceedings of the National Academy of Sciences of the United States of America

| volume = 96

| issue = 19

| pages = 10911–10916

| year = 1999

| pmid = 10485925

| pmc = 17982

| bibcode = 1999PNAS...9610911H | doi-access = free }}{{Cite journal

| doi = 10.1007/s003359900551

| last1 = Rogers | first1 = D. C.

| last2 = Fisher | first2 = E. M.

| last3 = Brown | first3 = S. D.

| last4 = Peters | first4 = J.

| last5 = Hunter | first5 = A. J.

| authorlink5 = Jackie Hunter

| last6 = Martin | first6 = J. E.

| title = Behavioral and functional analysis of mouse phenotype: SHIRPA, a proposed protocol for comprehensive phenotype assessment

| journal = Mammalian Genome

| volume = 8

| issue = 10

| pages = 711–713

| year = 1997

| pmid = 9321461

| s2cid = 29864514 }}{{Cite journal

| doi = 10.1046/j.1460-9568.2000.00919.x

| last1 = Piper | first1 = D. C.

| last2 = Upton | first2 = N.

| last3 = Smith | first3 = M. I.

| last4 = Hunter | first4 = A. J.

| title = The novel brain neuropeptide, orexin-A, modulates the sleep-wake cycle of rats

| journal = The European Journal of Neuroscience

| volume = 12

| issue = 2

| pages = 726–730

| year = 2000

| pmid = 10712652

| s2cid = 7052019 }}{{Cite journal | last1 = Brown | first1 = S. D. M. | last2 = Peters | first2 = P. M. | last3 = Strivens | first3 = J. | last4 = Rogers | first4 = M. | last5 = Hagan | first5 = D. | last6 = Spurr | first6 = J. | last7 = Gray | first7 = N. | last8 = Vizor | first8 = I. C. | last9 = Brooker | first9 = L. | last10 = Whitehill | first10 = D. | last11 = Washbourne | first11 = E. | last12 = Hough | first12 = R. | last13 = Greenaway | first13 = T. | last14 = Hewitt | first14 = S. | last15 = Liu | first15 = M. | last16 = McCormack | first16 = X. | last17 = Pickford | first17 = S. | last18 = Selley | first18 = K. | last19 = Wells | first19 = R. | last20 = Tymowska-Lalanne | first20 = C. | last21 = Roby | first21 = Z. | last22 = Glenister | first22 = P. | last23 = Thornton | first23 = P. | last24 = Thaung | first24 = C. | last25 = Stevenson | first25 = C. | last26 = Arkell | first26 = J. A. | last27 = Mburu | journal = Nature Genetics | first30 = A. | last30 = Erven | volume = 25 | title = A systematic, genome-wide, phenotype-driven mutagenesis programme for gene function studies in the mouse | pages = 440–443 | issue = 4 | first29 = R. | last28 = Hardisty | first27 = R. | year = 2000 | last29 = Kiernan | doi = 10.1038/78140 | first28 = P. | pmid = 10932191| s2cid = 9028853 }}{{Cite journal | last1 = Piper | first1 = D. C. | last2 = Upton | first2 = N. | last3 = Smith | first3 = M. I. | last4 = Hunter | first4 = A. J. | title = The novel brain neuropeptide, orexin-A, modulates the sleep-wake cycle of rats | doi = 10.1046/j.1460-9568.2000.00919.x | journal = European Journal of Neuroscience | volume = 12 | issue = 2 | pages = 726–730 | year = 2000 | pmid = 10712652| s2cid = 7052019 }} which was established as a consultancy for the promotion of open innovation in the life sciences, working with governments, academic organisations and companies to formulate open innovation strategies and best practice.

In 2013, Hunter was appointed CEO of the BBSRC.{{cite web|url=http://www.bbsrc.ac.uk/news/people-skills-training/2013/130604-pr-next-chief-executive-announced.aspx |title=Bioscience innovation leader appointed as next BBSRC Chief Executive |archiveurl=https://web.archive.org/web/20131204125436/http://www.bbsrc.ac.uk/news/people-skills-training/2013/130604-pr-next-chief-executive-announced.aspx |archivedate=4 December 2013 |url-status=dead }}{{cite web|url=http://www.gov.uk/government/news/new-chief-executive-for-the-biotechnology-and-biological-sciences-research-council |title=Press release: New chief executive for the Biotechnology and Biological Sciences Research Council |archivedate=14 May 2014 |archiveurl=https://web.archive.org/web/20140514183741/https://www.gov.uk/government/news/new-chief-executive-for-the-biotechnology-and-biological-sciences-research-council |url-status=dead }} She has also been a non-executive director of Proximagen group plc and Chiltern International Group (2016–present). She was a member of the governing councils of Royal Holloway and Bedford College, University of London and of Hertfordshire University. In 2016 she left the BBSRC and joined Stratified Medical which became BenevolentAI, establishing the drug discovery arm of the organisation. She retired from BenevolentAI in 2020 but remains as a board director. In 2019 she was appointed chair of the trustees of the Sainsbury Laboratories at Norwich. In 2020 she was also appointed as chair of the board of the Stevenage Bioscience Catalyst and chair of the board of Brainomix, an AI enabled imaging company.

Awards

{{BLP sources section|date=February 2021}}

References

{{reflist}}